Inherited retinal diseases and overview of gene therapy in eyecare

About the session

Inherited retinal diseases are the biggest single cause of blindness registration in working age individuals in several countries. Although the majority are untreatable, significant advances have been made in recent years in understanding the genetic basis and in making progress towards therapies. 

This session will discuss the latest in management of patients with inherited retinal disease, the top genetic causes, and new therapies on the horizon. The session will also discuss gene therapies that are being developed, both for inherited retinal diseases and for wider retinal conditions.

Learning outcomes

Learning outcomes and CPD information to be confirmed.


Professor Omar Mahroo

Omar Mahroo is a consultant ophthalmologist at Moorfields Eye Hospital and St Thomas’ Hospital, managing patients with inherited retinal disease. He is also Professor of Retinal Neuroscience at University College London. 

Omar completed his medical degree and PhD at the University of Cambridge, and his ophthalmology training in London, including a retinal fellowship at Moorfields Eye Hospital. He leads a programme of research investigating retinal function in health and disease, having received several research grants, including a £1.1 million Wellcome Trust award. He has authored over 120 publications and several book chapters and regularly lectures internationally.